| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| o-甲酚-d7 | (2)H7-o-cresol | 202325-50-6 | C7H8O |
| o-甲酚-d3(甲基-d3) | 2-<(D3)methyl>phenol | 70837-27-3 | C7H8O |
| o-甲苯酚酸钠 | (4-chloro-2-sulfamoylphenoxy)-acetic acid | 4486-75-3 | C8H8ClNO5S |
| o-甲苯甲酰-5-羟基奥美拉唑 | o-Toluoyl-5-hydroxy Omeprazole | 120003-79-4 | C25H25N3O5S |
| o-氧化甲氧基苯胺 | N,N'-bis<(2-methoxy)phenyl>oxamide | 21021-99-8 | C16H16N2O4 |
| o-异壬基苯酚 | methylmalonyl-CoA | 73173-91-8 | C25H40N7O19P3S |
| o-仲-丁基-α,α,&#x3B2,&#x3B2-四氟苯乙醚 | 1,4,5,8-tetrakis-cyclohexylamino-anthraquinone | 28634-38-0 | C38H52N4O2 |
| o-[[[2-[[2-(1,3-二氢-1,3-二羰基-2H-异吲哚-2-基)乙基](羟甲基)氨基]乙基]氨基]羰基]苯甲酸,混合物和2,2'-亚氨基二乙醇(1:1) | Einecs 309-228-8 | 100145-55-9 | C25H32N4O8 |
| o-[[1-羟基-6-[[[[2-甲氧基-5-甲基-4-[[8-[(苯基磺基基)氧代]-3,6-二磺基-1-萘基]偶氮]苯基]氨基]羰基]氨基]-3-磺基-2-萘基]偶氮]苯甲酸,钠盐 | 1-(1,2,3,5,6,7-hexahydro-s-indacen-4-yl)-N,2-dimethylpropan-2-amine;hydron;chloride | —— | C17H26ClN |
| o-[1-(1,4-二甲氧基-2-萘基)乙基]苯甲酸 | o-<1-(1,4-dimethoxy-2-naphthyl)ethyl>benzoic acid | 102235-11-0 | C21H20O4 |
| o-[1-(1,4-二甲氧基-2-萘基)乙基]苯基甲基甲醇 | o-<1-(1,4-dimethoxy-2-naphthyl)ethyl>phenylmethylcarbinol | 102235-13-2 | C22H24O3 |
| o-[(甲硫基)甲基]苯酚 | o-(methylthiomethyl)-phenol | 4526-41-4 | C8H10OS |
| o-[(4-甲氧基苯基)甲基]s-硫代羧酸苯酯 | Carbonothioic acid, O-((4-methoxyphenyl)methyl) S-phenyl ester | 62778-21-6 | C15H14O3S |
| o-1,5-薄荷二烯 | o-1,5-menthadiene | 527-83-3 | C10H16 |
| o-(环丙基甲氧基)苯酚 | 2-(cyclopropylmethoxy)phenol | 25947-69-7 | C10H12O2 |
| o-(己氧基)碳杂酰苯胺酸1-乙基-4-哌啶基酯盐酸 | (1-Ethylpiperidin-1-ium-4-yl)n-(2-hexoxyphenyl)carbamate chloride | 105383-98-0 | C20H33ClN2O3 |
| o-(4-羟基苯基)-3,5-二碘-L-酪氨酸甲酯 | 3,5-diiodo-L-thyronine methyl ester | 203585-45-9 | C16H15I2NO4 |
| o-(1-氨基-1-甲基乙基)苯酚 | o-(1-amino-1-methylethyl)phenol | 117343-33-6 | C9H13NO |
| o,p-二甲苯 | Phenyl-phosphonic acid bis-(2,5-dichloro-phenyl) ester | 71432-26-3 | C18H11Cl4O3P |
| o,p'-甲氧滴滴涕 | 1,1,1-trichloro-2-(2-methoxyphenyl)-2-(4-methoxyphenyl)ethane | 30667-99-3 | C16H15Cl3O2 |
| [[O-(烯丙氧基)苯氧基]甲基]环氧乙烷 | 1-(2-allyloxyphenoxy)-2,3-epoxypropane | 6452-72-8 | C12H14O3 |
| O,α-二甲基-L-酪氨酸盐酸盐 | (2S)-2-amino-3-(4-methoxyphenyl)-2-methylpropanoic acid hydrochloride | 35026-10-9 | C11H15NO3*ClH |
| O,O’-二乙基-(2-琥珀酸二乙酯基)膦酸酯 | diethyl 2-(diethoxyphosphoryl)succinate | 7071-15-0 | C12H23O7P |
| O型304 | 4-chloro-N-[2-[(4-chlorophenyl)methyl]-3-oxo-1,2,4-thiadiazol-5-yl]benzamide | 1261289-04-6 | C16H11Cl2N3O2S |
| Ox吲哚-4-硼酸频那醇酯 | 4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)indolin-2-one | 1150271-44-5 | C14H18BNO3 |
| OtBu-L-谷氨酸甲酯盐酸盐 | L-glutamic acid 5-tert-butyl 1-methyl ester hydrochloride | 6234-01-1 | C10H19NO4*ClH |
| Orteronel; 6-[(7S)-7-羟基-6,7-二氢-5H-吡咯并[1,2-c]咪唑-7-基]-N-甲基-2-萘甲酰胺 | Orteronel | 566939-85-3 | C18H17N3O2 |
| Org24598锂盐;R-(-)-N-甲基-N-[(3R)-3-苯基-3-[4-(三氟甲基)苯氧基]丙基]甘氨酸锂 | Org 24598 lithium salt | 722456-08-8 | C19H19F3LiNO3 |
| Oprozomib(ONX-0912)抑制剂 | oprozomib | 935888-69-0 | C25H32N4O7S |
| Oplopanone; 10alpha-羟基日本刺参萜-4-酮 | oplopanone | 1911-78-0 | C15H26O2 |
| Oplodiol; (1S,4R,4aR,8aR)-1,2,3,4,4a,5,8,8a-八氢-1,4a-二甲基-7-(1-甲基乙基)-1,4-二羟基萘 | 1β,4β-dihydroxy-trans-eudesm-7-ene | 13902-62-0 | C15H26O2 |
| Ono-4007单钠盐 | Ono-4007 sodium salt | 152646-95-2 | C50H78NNaO12S |
| Omi/HtrA2蛋白酶抑制剂,Ucf-101 | High Temperature Requirement A2 Inhibitor I | 313649-08-0 | C27H17N3O5S |
| Oleoside; (2S,3E,4S)-5-羧基-3-亚乙基-2-(beta-D-吡喃葡萄糖氧基)-3,4-二氢-2H-吡喃-4-乙酸 | oleoside | 178600-68-5 | C16H22O11 |
| Olcegepant; N-[2-[5-氨基-1(S)-[4-(4-吡啶基)哌嗪-1-甲酰基]戊基氨基]-1(R)-(3,5-二溴-4-羟基苄基)-2-氧代乙基]-4-(2-氧代-1,2,3,4-四氢喹唑啉-3-基)哌啶-1-甲酰胺 | Olcegepant | 204697-65-4 | C38H47Br2N9O5 |
| Odoratone;22,25-环氧-23,24-二羟基-13alpha,14beta,17betaH-羊毛甾-7-烯-3-酮 | Odoratone | 16962-90-6 | C30H48O4 |
| Odanacatib中间体 | ethyl 2-amino-4-methylpent-4-enoate | 68843-73-2 | C8H15NO2 |
| Octahydroazocine盐酸盐 | azocane hydrochloride | 36520-41-9 | C7H15N*ClH |
| Oblongine;(S)-1,2,3,4-四氢-8-羟基-1-[(4-羟基苯基)甲基]-7-甲氧基-2,2-二甲基异喹啉 | (1S)-1-[(4-hydroxyphenyl)methyl]-7-methoxy-2,2-dimethyl-3,4-dihydro-1H-isoquinolin-2-ium-8-ol | 60008-01-7 | C19H24NO3+ |
| Obatoclax甲磺酸盐 | Obatoclax mesylate | 803712-79-0 | C21H23N3O4S |
| OZANIMOD中间体 | (R)-tert-butyl 4-cyano-2,3-dihydro-1H-inden-1-ylcarbamate | 1306763-30-3 | C15H18N2O2 |
| OZ439标准品 | 4-(2-(4-(dispiro[adamantane-2,3'-[1,2,4]trioxolane-5',1''-cyclohexan]-4''-yl)phenoxy)ethyl)morpholine | 1029939-86-3 | C28H39NO5 |
| OTSSP167盐酸盐 | OTSSP167 hydrochloride | 1431698-10-0 | C25H29Cl3N4O2 |
| OSI-027; 反式-4-[4-氨基-5-(7-甲氧基-1H-吲哚-2-基)咪唑并[5,1-f][1,2,4]三嗪-7-基]环己烷羧酸 | OSI-027 | 936890-98-1 | C21H22N6O3 |
| OSI 420; 2-[[4-[(3-乙炔基苯基)氨基]-7-(2-甲氧基乙氧基)-6-喹唑啉基]氧]乙醇盐酸盐 | 2-[4-(3-Ethynyl-phenylamino)-7-(2-methoxy-ethoxy)-quinazolin-6-yloxy]-ethanol hydrochloride | 183320-51-6 | C21H21N3O4*ClH |
| ORL1拮抗剂1 | ORL1 antagonist 1 | 1174985-59-1 | C20H22ClN5 |
| OPC-920257中间体 | L-leucyl-L-phenylalanine methyl ester | 38155-18-9 | C16H24N2O3 |
| OO-叔-丁基 O-环己基过氧碳酸酯 | percarbonate de O,O-t-butyl et O-cyclohexyl | 21690-93-7 | C11H20O4 |
| ONX-0914(PR-957)抑制剂 | Onx-0914 (PR-957) | 960374-59-8 | C31H40N4O7 |
| ONO 8711; (5Z)-6-[(2R,3S)-3-[[[(4-氯-2-甲基苯基)磺酰基]氨基]甲基]双环[2.2.2]辛-2-基]-5-己烯酸 | 6-[(2R,3S)-3-[[[(4-chloro-2-methylphenyl)sulfonyl]amino]methyl]bicyclo[2.2.2]oct-2-yl]-5Z-hexenoic acid | 216158-34-8 | C22H30ClNO4S |